ESOPHAGOGASTRIC CANCER
Clinical trials for ESOPHAGOGASTRIC CANCER explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGOGASTRIC CANCER trials appear
Sign up with your email to follow new studies for ESOPHAGOGASTRIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cell therapy shows promise for tough cancers
Disease control OngoingThis phase 2 study tests a personalized immune cell therapy called tumor-infiltrating lymphocytes (TIL) in 20 people with advanced solid cancers (like stomach, colon, or pancreatic cancer) that have not responded to standard treatments. Patients first receive chemotherapy to prep…
Matched conditions: ESOPHAGOGASTRIC CANCER
Phase: PHASE2 • Sponsor: Udai Kammula • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Triple-Drug cocktail shows promise for tough stomach cancer
Disease control OngoingThis study tests whether combining an immunotherapy drug (nivolumab) with standard chemotherapy (FOLFOX) and a targeted therapy (regorafenib) can safely control HER2-negative metastatic esophagogastric cancer. About 39 adults with advanced cancer that has spread will receive the …
Matched conditions: ESOPHAGOGASTRIC CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New drug targets genetic weakness in hard-to-treat stomach cancer
Disease control OngoingThis phase 2 study tests whether amivantamab can shrink tumors in people with esophagogastric cancer that has a specific genetic change (EGFR or MET amplification). About 25 participants who have already tried at least one other treatment will receive the drug intravenously. The …
Matched conditions: ESOPHAGOGASTRIC CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New drug combo takes on advanced cancers in early trial
Disease control OngoingThis early-stage trial is testing a new drug called KFA115, either by itself or combined with the immunotherapy Keytruda (pembrolizumab), in 126 people with advanced cancers like lung, skin, kidney, and others. The main goal is to check safety and find the best dose. It is not ye…
Matched conditions: ESOPHAGOGASTRIC CANCER
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New light therapy aims to ease swallowing for esophageal cancer patients
Symptom relief OngoingThis early-phase trial tests a treatment called vascular-targeted photodynamic therapy (VTP) for people with advanced esophageal or stomach cancer who have moderate to severe trouble swallowing. The treatment uses a light-sensitive drug (WST-11) and a laser delivered through a th…
Matched conditions: ESOPHAGOGASTRIC CANCER
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Your teeth might reveal cancer risk: new study investigates
Knowledge-focused OngoingThis pilot study is looking at whether dental erosion (loss of tooth enamel) could be a non-invasive biomarker for esophagogastric cancer and other cancers. Researchers will survey 174 participants (cancer patients and healthy volunteers) about diet, habits, and GERD symptoms, an…
Matched conditions: ESOPHAGOGASTRIC CANCER
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC